UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Decreased by Foster & Motley Inc.

Foster & Motley Inc. lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,089 shares of the healthcare conglomerate’s stock after selling 288 shares during the quarter. Foster & Motley Inc.’s holdings in UnitedHealth Group were worth $3,560,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently bought and sold shares of the business. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group during the 3rd quarter worth $27,000. Global Wealth Strategies & Associates boosted its position in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the period. Macroview Investment Management LLC raised its stake in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. West Financial Advisors LLC acquired a new stake in UnitedHealth Group in the 3rd quarter worth $32,000. Finally, Delos Wealth Advisors LLC lifted its stake in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 5.0 %

UnitedHealth Group stock opened at $595.32 on Wednesday. The company has a market cap of $549.73 billion, a P/E ratio of 36.94, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The company has a fifty day simple moving average of $580.96 and a 200 day simple moving average of $543.36. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $608.63.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period last year, the company earned $6.56 earnings per share. The business’s revenue was up 9.2% compared to the same quarter last year. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.41%. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Upgrades and Downgrades

A number of analysts have commented on UNH shares. Truist Financial reiterated a “buy” rating and issued a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 24th. Robert W. Baird upped their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. KeyCorp started coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective on the stock. Finally, Argus boosted their price target on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.